{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T17:47:04Z","timestamp":1775065624551,"version":"3.50.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,24]]},"DOI":"10.7759\/cureus.56812","type":"journal-article","created":{"date-parts":[[2024,3,24]],"date-time":"2024-03-24T11:40:56Z","timestamp":1711280456000},"source":"Crossref","is-referenced-by-count":1,"title":["Association of Leukemia With ABO Blood Group Distribution and Discrepancy: A Review Article"],"prefix":"10.7759","author":[{"given":"Husham O","family":"Elzein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Distribution of ABO blood group types and rhesus factor among varies cancers (leukemia, lymphoma, breast and colon cancers) cross sectional study in Nablus City-Palestine","author":"Ghoul I","unstructured":"Ghoul I, Eid Y, Arabas H, Taqtuq A, Bradeia M, Basheer M. Distribution of ABO blood group types and rhesus factor among varies cancers (leukemia, lymphoma, breast and colon cancers) cross sectional study in Nablus City-Palestine."},{"key":"ref2","article-title":"World Health Statistics 2022: Monitoring Health for the SDGs, Sustainable Development Goals","author":"World Health Organizations","year":"2023","unstructured":"World Health Organizations. World Health Statistics 2022: Monitoring Health for the SDGs, Sustainable Development Goals. WHO, Geneva; 2023."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/vox.12787","article-title":"Biologic roles of the ABH and Lewis histo-blood group antigens part I: Infection and immunity","volume":"114","author":"Stowell CP","year":"2019","unstructured":"Stowell CP, Stowell SR. Biologic roles of the ABH and Lewis histo-blood group antigens part I: Infection and immunity. Vox Sang. 2019, 114:426-42. 10.1111\/vox.12787","journal-title":"Vox Sang"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0463.2000.d01-1.x","article-title":"Tissue distribution of histo-blood group antigens","volume":"108","author":"Ravn V","year":"2000","unstructured":"Ravn V, Dabelsteen E. Tissue distribution of histo-blood group antigens. APMIS. 2000, 108:1-28. 10.1034\/j.1600-0463.2000.d01-1.x","journal-title":"APMIS"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23158799","article-title":"A comprehensive prognostic analysis of tumor-related blood group antigens in pan-cancers suggests that SEMA7A as a novel biomarker in kidney renal clear cell carcinoma","volume":"23","author":"Wang Y","year":"2022","unstructured":"Wang Y, Li C, Qi X, et al.. A comprehensive prognostic analysis of tumor-related blood group antigens in pan-cancers suggests that SEMA7A as a novel biomarker in kidney renal clear cell carcinoma. Int J Mol Sci. 2022, 23:8799. 10.3390\/ijms23158799","journal-title":"Int J Mol Sci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6629060","article-title":"Human ABO blood groups and their associations with different diseases","volume":"2021","author":"Abegaz SB","year":"2021","unstructured":"Abegaz SB. Human ABO blood groups and their associations with different diseases. BioMed Res Int. 2021, 2021:10.1155\/2021\/6629060","journal-title":"BioMed Res Int"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v24.i48.5418","article-title":"Colorectal cancer vaccines: Tumor-associated antigens vs neoantigens","volume":"24","author":"Wagner S","year":"2018","unstructured":"Wagner S, Mullins CS, Linnebacher M. Colorectal cancer vaccines: Tumor-associated antigens vs neoantigens. World J Gastroenterol. 2018, 24:5418-32. 10.3748\/wjg.v24.i48.5418","journal-title":"World J Gastroenterol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1100\/tsw.2007.133","article-title":"ABO blood group. Related investigations and their association with defined pathologies","volume":"7","author":"Jesch U","year":"2007","unstructured":"Jesch U, Endler PC, Wulkersdorfer B, Spranger H. ABO blood group. Related investigations and their association with defined pathologies. Sci World J. 2007, 7:1151-4. 10.1100\/tsw.2007.133","journal-title":"Sci World J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-013-1027-4","article-title":"Hemostasis, cancer, and ABO blood group: The most recent evidence of association","volume":"38","author":"Liumbruno GM","year":"2014","unstructured":"Liumbruno GM, Franchini M. Hemostasis, cancer, and ABO blood group: The most recent evidence of association. J Thromb Thrombolysis. 2014, 38:160-6. 10.1007\/s11239-013-1027-4","journal-title":"J Thromb Thrombolysis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdt320","article-title":"Acute myeloblastic leukaemias in adult patients: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"24","author":"Fey MF","year":"2013","unstructured":"Fey MF, Buske C. Acute myeloblastic leukaemias in adult patients: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013, 24:vi138-43. 10.1093\/annonc\/mdt320","journal-title":"Ann Oncol"},{"key":"ref11","unstructured":"SEER cancer statistics review, 1975-2013. (2016). Accessed. January 15, 2024: https:\/\/seer.cancer.gov\/archive\/csr\/1975_2013\/."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2016.50","article-title":"Acute myeloid leukemia: A comprehensive review and 2016 update","volume":"6","author":"De Kouchkovsky I","year":"2016","unstructured":"De Kouchkovsky I, Abdul-Hay M. Acute myeloid leukemia: A comprehensive review and 2016 update. Blood Cancer J. 2016, 6:e441. 10.1038\/bcj.2016.50","journal-title":"Blood Cancer J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.33527","article-title":"Deleterious point mutations in T-cell acute lymphoblastic leukemia: Mechanistic insights into leukemogenesis","volume":"149","author":"Roy U","year":"2021","unstructured":"Roy U, Raghavan SC. Deleterious point mutations in T-cell acute lymphoblastic leukemia: Mechanistic insights into leukemogenesis. Int J Cancer. 2021, 149:1210-20. 10.1002\/ijc.33527","journal-title":"Int J Cancer"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw025","article-title":"Acute lymphoblastic leukaemia in adult patients: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"27","author":"Hoelzer D","year":"2016","unstructured":"Hoelzer D, Bassan R, Dombret H, Fielding A, Ribera JM, Buske C. Acute lymphoblastic leukaemia in adult patients: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016, 27:v69-82. 10.1093\/annonc\/mdw025","journal-title":"Ann Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.5505\/aot.2020.97720","article-title":"The relationship between ABO and Rh blood groups with acute lymphoblastic leukemia","volume":"53","author":"Ba\u015fc\u0131 S","year":"2020","unstructured":"Ba\u015fc\u0131 S, Yi\u011feno\u011flu TN, \u015eahin D, et al.. The relationship between ABO and Rh blood groups with acute lymphoblastic leukemia. Acta Oncologica Turcica. 2020, 53:357-61. 10.5505\/aot.2020.97720","journal-title":"Acta Oncologica Turcica"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-004-0888-1","article-title":"Distribution of ABO blood groups in acute leukaemias and lymphomas","volume":"83","author":"Vadivelu MK","year":"2004","unstructured":"Vadivelu MK, Damodaran S, Solomon J, Rajaseharan A. Distribution of ABO blood groups in acute leukaemias and lymphomas. Ann Hematol. 2004, 83:584-7. 10.1007\/s00277-004-0888-1","journal-title":"Ann Hematol"},{"key":"ref17","article-title":"Relationship between ABO blood group and acute lymphoblastic leukemia","volume":"4","author":"Tavasolian F","year":"2014","unstructured":"Tavasolian F, Abdollahi E, Vakili M, Amini A. Relationship between ABO blood group and acute lymphoblastic leukemia. Iran J Pediatr Hematol Oncol. 2014, 4:1.","journal-title":"Iran J Pediatr Hematol Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.17532\/jhsci.2012.41","article-title":"Distribution of ABO blood group in children with acute leukemias","volume":"2","author":"Saki\u0107 M","year":"2012","unstructured":"Saki\u0107 M. Distribution of ABO blood group in children with acute leukemias. J Health Sci. 2012, 2:220-3. 10.17532\/jhsci.2012.41","journal-title":"J Health Sci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s002770050507","article-title":"Why is acute leukemia more common in males? A possible sex-determined risk linked to the ABO blood group genes","volume":"78","author":"Jackson N","year":"1999","unstructured":"Jackson N, Menon BS, Zarina W, Zawawi N, Naing NN. Why is acute leukemia more common in males? A possible sex-determined risk linked to the ABO blood group genes. Ann Hematol. 1999, 78:233-6. 10.1007\/s002770050507","journal-title":"Ann Hematol"},{"key":"ref20","article-title":"Association between the phenotype of the blood group system AB0 and Leukemia","volume":"30","author":"Mart\u00ednez-Romero A","year":"2019","unstructured":"Mart\u00ednez-Romero A, Ochoa-Garc\u00eda PP, Garc\u00eda-Contreras LO, et al.. Association between the phenotype of the blood group system AB0 and Leukemia. Biomed Res. 2019, 30:639-44.","journal-title":"Biomed Res"},{"key":"ref21","article-title":"Blood Groups Relationship with Incidence of Malignancy in Children","author":"Abd-Allateef MH","year":"2021","unstructured":"Abd-Allateef MH. Blood Groups Relationship with Incidence of Malignancy in Children. University of Diyala, 2021."},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1080\/08880010600907221","article-title":"Distribution of ABO blood groups in childhood acute leukemia","volume":"1","author":"Alavi S","year":"2006","unstructured":"Alavi S, Ashraf H, Rashidi A, Hosseini N, Abouzari M, Naderifar M. Distribution of ABO blood groups in childhood acute leukemia. Pediatr Hematol Oncol. 2006, 1:611-7. 10.1080\/08880010600907221","journal-title":"Pediatr Hematol Oncol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.9790\/7388-0702038689","article-title":"Relationship between ABO and Rh blood groups with childhood acute lymphoblastic leukemia","volume":"5","author":"Ghali HH","year":"2017","unstructured":"Ghali HH, Nayeef AM, Hameed AH, Fawzi GM. Relationship between ABO and Rh blood groups with childhood acute lymphoblastic leukemia. IOSR Int J Res Method Educ. 2017, 5:9. 10.9790\/7388-0702038689","journal-title":"IOSR Int J Res Method Educ"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2019.07.037","article-title":"The relationship between ABO and rhesus blood groups and acute lymphoblastic leukemia","volume":"19","author":"Sahin D","year":"2019","unstructured":"Sahin D, Yigenoglu T, Darc\u0131n T, et al.. The relationship between ABO and rhesus blood groups and acute lymphoblastic leukemia. Clin Lymphoma Myeloma Leuk. 2019, 19:192. 10.1016\/j.clml.2019.07.037","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref25","article-title":"Socio-demographic and blood group findings in children with acute leukemia: A single cancer center experience","volume":"22","author":"Abdulkareem AG","year":"2020","unstructured":"Abdulkareem AG, Ali NO, Mahmood CA, Ome WD, Ahmad HM, Ali AK. Socio-demographic and blood group findings in children with acute leukemia: A single cancer center experience. Govari Zankoi Silemani A Zaniste Sirustiye. 2020, 22:17-24.","journal-title":"Govari Zankoi Silemani A Zaniste Sirustiye"},{"key":"ref26","article-title":"Distribution of blood groups in different types of leukemia patients in Eski\u015fehir, Turkey","volume":"3","author":"Fatih KA","year":"2018","unstructured":"Fatih KA, Andic N, Kiraz ZK, et al.. Distribution of blood groups in different types of leukemia patients in Eski\u015fehir, Turkey. Turk J Life Sci. 2018, 3:214-7.","journal-title":"Turk J Life Sci"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21208","article-title":"Cancer statistics, 2014","volume":"64","author":"Siegel R","year":"2014","unstructured":"Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014, 64:9-29. 10.3322\/caac.21208","journal-title":"CA Cancer J Clin"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.32322\/jhsm.684289","article-title":"The relationship between blood groups and acute myeloid leukemia","volume":"6","author":"\u015eahin D","year":"2020","unstructured":"\u015eahin D, Basci S, Temizel A, et al.. The relationship between blood groups and acute myeloid leukemia. J Health Sci Med. 2020, 6:221-4. 10.32322\/jhsm.684289","journal-title":"J Health Sci Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2016.06.005","article-title":"ABO blood group and risk of cancer: A register-based cohort study of 1.6 million blood donors","volume":"44","author":"Vasan SK","year":"2016","unstructured":"Vasan SK, Hwang J, Rostgaard K, et al.. ABO blood group and risk of cancer: A register-based cohort study of 1.6 million blood donors. Cancer Epidemiol. 2016, 44:40-3. 10.1016\/j.canep.2016.06.005","journal-title":"Cancer Epidemiol"},{"key":"ref30","article-title":"Association of some blood group phenotypes and risk of acute myeloid leukaemia In Kano, Nigeria","volume":"1","author":"Garba N","year":"2022","unstructured":"Garba N, Ahmad SG, Makuku UA, et al.. Association of some blood group phenotypes and risk of acute myeloid leukaemia In Kano, Nigeria. Afr J Lab Haem Trans Sci. 2022, 1:148-57.","journal-title":"Afr J Lab Haem Trans Sci"},{"key":"ref31","article-title":"Effect of age, gender and blood group on different types of leukemia","volume":"15","author":"Zand AM","year":"2010","unstructured":"Zand AM, Imani S, Sa\u2019adati M, et al.. Effect of age, gender and blood group on different types of leukemia. Kowsar Med J. 2010, 15:111-4.","journal-title":"Kowsar Med J"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.7314\/apjcp.2016.17.3.1547","article-title":"Prognostic factors and survival in acute myeloid leukemia cases: A report from the Northeast of Iran","volume":"17","author":"Allahyari A","year":"2016","unstructured":"Allahyari A, Tajeri T, Sadeghi M. Prognostic factors and survival in acute myeloid leukemia cases: A report from the Northeast of Iran. Asian Pac J Cancer Prev. 2016, 17:1547-51. 10.7314\/apjcp.2016.17.3.1547","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.5958\/0974-4517.2022.00015.5","article-title":"Distribution of ABO blood groups in acute leukemia patients in Sulaymaniyah, Kurdistan region of Iraq","volume":"24","author":"Hama HA","year":"2022","unstructured":"Hama HA, Hamatahir SK, Sirwan Y. Distribution of ABO blood groups in acute leukemia patients in Sulaymaniyah, Kurdistan region of Iraq. Appl Biol Res. 2022, 24:119-125. 10.5958\/0974-4517.2022.00015.5","journal-title":"Appl Biol Res"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.4103\/jfmpc.jfmpc_1245_19","article-title":"Hematological malignancies in relation with ABO blood group at a teaching hospital, Varanasi, India","volume":"9","author":"Kumar S","year":"2020","unstructured":"Kumar S, Mahto N, Bharti A, Meena LP. Hematological malignancies in relation with ABO blood group at a teaching hospital, Varanasi, India. J Family Med Prim Care. 2020, 9:2309-12. 10.4103\/jfmpc.jfmpc_1245_19","journal-title":"J Family Med Prim Care"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMct071828","article-title":"BCR-ABL tyrosine kinase inhibitors for chronic myelogenous leukemia","volume":"357","author":"Schiffer CA","year":"2007","unstructured":"Schiffer CA. BCR-ABL tyrosine kinase inhibitors for chronic myelogenous leukemia. N Engl J Med. 2007, 357:258-65. 10.1056\/NEJMct071828","journal-title":"N Engl J Med"},{"key":"ref36","article-title":"Distribution of ABO blood groups and Rh blood factor in chronic myeloid leukemia patients","volume":"2","author":"Shahzad H","year":"2013","unstructured":"Shahzad H, Asad MJ, Masood T, Noor-ul-Amin M, Raja AM, Ijaz S, Mahmood RT. Distribution of ABO blood groups and Rh blood factor in chronic myeloid leukemia patients. J Pub Health Bio Sci. 2013, 2:197-200.","journal-title":"J Pub Health Bio Sci"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.29409\/ijcmg.v5i1.73","article-title":"Distribution of ABO blood groups in Iraqi samples of leukemia and lymphomas","volume":"1","author":"Ad\u2019hiah AH","year":"2012","unstructured":"Ad\u2019hiah AH, Ali EN. Distribution of ABO blood groups in Iraqi samples of leukemia and lymphomas. Iraqi J Cancer Med Genet. 2012, 1:16-21. 10.29409\/ijcmg.v5i1.73","journal-title":"Iraqi J Cancer Med Genet"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.4238\/vol7-1gmr401","article-title":"ABO genotyping in leukemia patients reveals new ABO variant alleles","volume":"7","author":"Novaretti MC","year":"2008","unstructured":"Novaretti MC, Domingues AE, Manhani R, Pinto EM, Dorlhiac-Llacer PE, Chamone DA. ABO genotyping in leukemia patients reveals new ABO variant alleles. Genet Mol Res. 2008, 7:87-94. 10.4238\/vol7-1gmr401","journal-title":"Genet Mol Res"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.5152\/eurasianjmed.2023.21124","article-title":"The distribution and phenotypes of blood groups in hematologic malignancies","volume":"55","author":"Erdemir M","year":"2023","unstructured":"Erdemir M, Erdem F, Sincan G. The distribution and phenotypes of blood groups in hematologic malignancies. Eurasian J Med. 2023, 55:20-4. 10.5152\/eurasianjmed.2023.21124","journal-title":"Eurasian J Med"},{"key":"ref40","article-title":"Distribution of ABO and rh blood group in myeloproliferative diseases","volume":"5","author":"Yadav S","year":"20181","unstructured":"Yadav S, Chaudhary J, Kumar N, Kannauje PK, Kumar K, Bhattnagar R, Tiwari R. Distribution of ABO and rh blood group in myeloproliferative diseases. Acta Medica Int. 20181, 5:39.","journal-title":"Acta Medica Int"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.4103\/jfmpc.jfmpc_2167_21","article-title":"Clinical spectrum and treatment response in patient of chronic myeloid leukemia in correlation with ABO blood group","volume":"11","author":"Meher MP","year":"2022","unstructured":"Meher MP, Gupta S, Singh AK, et al.. Clinical spectrum and treatment response in patient of chronic myeloid leukemia in correlation with ABO blood group. J Family Med Prim Care. 2022, 11:3449-54. 10.4103\/jfmpc.jfmpc_2167_21","journal-title":"J Family Med Prim Care"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.37506\/ijfmt.v15i2.14674","article-title":"Relationship between blood group and chronic myeloid leukemia with the role of the oxidative stress","volume":"15","author":"Salih BS","year":"2021","unstructured":"Salih BS, Hassan AS. Relationship between blood group and chronic myeloid leukemia with the role of the oxidative stress. Indian J Forensic Med Toxicol. 2021, 15:10. 10.37506\/ijfmt.v15i2.14674","journal-title":"Indian J Forensic Med Toxicol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.14553","article-title":"Chronic lymphocytic leukemia: A clinical review","volume":"312","author":"Nabhan C","year":"2014","unstructured":"Nabhan C, Rosen ST. Chronic lymphocytic leukemia: A clinical review. JAMA. 2014, 312:2265-76. 10.1001\/jama.2014.14553","journal-title":"JAMA"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26367","article-title":"Chronic lymphocytic leukemia: 2022 update on diagnostic and therapeutic procedures","volume":"96","author":"Hallek M","year":"2021","unstructured":"Hallek M, Al-Sawaf O. Chronic lymphocytic leukemia: 2022 update on diagnostic and therapeutic procedures. Am J Hematol. 2021, 96:1679-705. 10.1002\/ajh.26367","journal-title":"Am J Hematol"},{"key":"ref45","article-title":"Study of sex ratio ABO and Rh blood groups distribution in some haematological and lymphatic diseases in Iran","volume":"24","author":"Farhud DD","year":"1995","unstructured":"Farhud DD, Sadighi H, Andonian L, Saffari M. Study of sex ratio ABO and Rh blood groups distribution in some haematological and lymphatic diseases in Iran. Iran J Public Health. 1995, 24:9-14.","journal-title":"Iran J Public Health"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/0165-4608(91)90016-n","article-title":"ABO blood groups in hematologic malignancies","volume":"51","author":"Janardhana V","year":"1991","unstructured":"Janardhana V, Propert DN, Green RE. ABO blood groups in hematologic malignancies. Cancer Genet Cytogenet. 1991, 51:113-20. 10.1016\/0165-4608(91)90016-n","journal-title":"Cancer Genet Cytogenet"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1963.03710120035007","article-title":"Chronic lymphocytic leukemia or lymphoma and carcinoma of the colon: Correlation with blood type A","volume":"186","author":"Hyman GA","year":"1963","unstructured":"Hyman GA, Ultmann JE, Slanetz CA. Chronic lymphocytic leukemia or lymphoma and carcinoma of the colon: Correlation with blood type A. JAMA. 1963, 186:1053-6. 10.1001\/jama.1963.03710120035007","journal-title":"JAMA"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v97.11.3633","article-title":"Loss of red cell A, B, and H antigens is frequent in myeloid malignancies","volume":"97","author":"Bianco T","year":"2001","unstructured":"Bianco T, Farmer BJ, Sage RE, Dobrovic A. Loss of red cell A, B, and H antigens is frequent in myeloid malignancies. Blood. 2001, 97:3633-9. 10.1182\/blood.v97.11.3633","journal-title":"Blood"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.15562\/ijbs.v17i1.428","article-title":"Change of ABO blood group in a patient with acute myelocytic leukemia (AML): A case report","volume":"14","author":"Sari NKP","year":"2023","unstructured":"Sari NKP, Mulyantari NK, Herawati S, Lestari AA, Mahartini NN, Wande IN. Change of ABO blood group in a patient with acute myelocytic leukemia (AML): A case report. IJBS. 2023, 14:428. 10.15562\/ijbs.v17i1.428","journal-title":"IJBS"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1080\/08998280.2017.11929536","article-title":"Blood group change in acute myeloid leukemia","volume":"30","author":"Nambiar RK","year":"2017","unstructured":"Nambiar RK, Narayanan G, Prakash NP, Vijayalakshmi K. Blood group change in acute myeloid leukemia. Proc (Bayl Univ Med Cent). 2017, 30:74-5. 10.1080\/08998280.2017.11929536","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-009-0858-8","article-title":"ABO discrepancy in an elderly patient with IgA kappa-type multiple myeloma","volume":"89","author":"Kim SY","year":"2010","unstructured":"Kim SY, Oh SH, Park KS, et al.. ABO discrepancy in an elderly patient with IgA kappa-type multiple myeloma. Ann Hematol. 2010, 89:747-8. 10.1007\/s00277-009-0858-8","journal-title":"Ann Hematol"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0004788","article-title":"DNA methylation of the ABO promoter underlies loss of ABO allelic expression in a significant proportion of leukemic patients","volume":"4","author":"Bianco-Miotto T","year":"2009","unstructured":"Bianco-Miotto T, Hussey DJ, Day TK, O'Keefe DS, Dobrovic A. DNA methylation of the ABO promoter underlies loss of ABO allelic expression in a significant proportion of leukemic patients. PLoS One. 2009, 4:e4788. 10.1371\/journal.pone.0004788","journal-title":"PLoS One"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1111\/trf.15628","article-title":"RUNX1 mutation in a patient with myelodysplastic syndrome and decreased erythrocyte expression of blood group A antigen","volume":"60","author":"Hayakawa A","year":"2020","unstructured":"Hayakawa A, Sano R, Takahashi Y, et al.. RUNX1 mutation in a patient with myelodysplastic syndrome and decreased erythrocyte expression of blood group A antigen. Transfusion. 2020, 60:184-96. 10.1111\/trf.15628","journal-title":"Transfusion"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1957.tb03429.x","article-title":"Two A antigens with abnormal serologic properties","volume":"2","author":"Van Loghem Jr JJ","year":"1957","unstructured":"Van Loghem Jr JJ, Dorfmeier H, Van der Hart M. Two A antigens with abnormal serologic properties. Vox Sang. 1957, 2:16-24. 10.1111\/j.1423-0410.1957.tb03429.x","journal-title":"Vox Sang"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1016\/S0268-960X(99)90020-6","article-title":"Functional aspects of red cell antigens","volume":"13","author":"Daniels G","year":"19991","unstructured":"Daniels G. Functional aspects of red cell antigens. Blood Rev. 19991, 13:14-35. 10.1016\/S0268-960X(99)90020-6","journal-title":"Blood Rev"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.29309\/TPMJ\/2022.29.10.7142","article-title":"Blood group discrepancies in leukemia children: A cross sectional study","volume":"30","author":"Fateen T","year":"2022","unstructured":"Fateen T, Chaudhary HT, Saqlain N, Arshad S, Anam N, ur Rehman A, Ahsan M. Blood group discrepancies in leukemia children: A cross sectional study. TPMJ. 2022, 30:1553-7. 10.29309\/TPMJ\/2022.29.10.7142","journal-title":"TPMJ"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.2298\/MPNS2210314G","article-title":"Resolving blood group discrepancy in a patient with acute myeloid leukemia: A case report","volume":"75","author":"Gruji\u0107 J","year":"2022","unstructured":"Gruji\u0107 J, Bujandri\u0107 N, Malenkovi\u0107 G. Resolving blood group discrepancy in a patient with acute myeloid leukemia: A case report. Med Pregl. 2022, 75:314-6. 10.2298\/MPNS2210314G","journal-title":"Med Pregl"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2014.11.004","article-title":"Red cell antigen loss in a patient with chronic myeloid leukemia: A case of ABO discrepancy","volume":"52","author":"Shafiq M","year":"2015","unstructured":"Shafiq M, Karim F. Red cell antigen loss in a patient with chronic myeloid leukemia: A case of ABO discrepancy. Transfus Apher Sci. 2015, 52:103-4. 10.1016\/j.transci.2014.11.004","journal-title":"Transfus Apher Sci"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1016\/j.kjms.2016.06.004","article-title":"Discrepancy of ABO typing in acute leukemia patients","volume":"32","author":"Ting SC","year":"2016","unstructured":"Ting SC, Sainamthip P, Hsiao HH, Liu TC. Discrepancy of ABO typing in acute leukemia patients. Kaohsiung J Med Sci. 2016, 32:595-6. 10.1016\/j.kjms.2016.06.004","journal-title":"Kaohsiung J Med Sci"},{"key":"ref60","article-title":"Loss of red cell A antigen in a patient with acute myeloid leukemia: A case report and review of the literature","volume":"30","author":"Cho JH","year":"2011","unstructured":"Cho JH, Hur M, Moon HW, et al.. Loss of red cell A antigen in a patient with acute myeloid leukemia: A case report and review of the literature. Korean J Blood Transfus. 2011, 30:277-83.","journal-title":"Korean J Blood Transfus"},{"key":"ref61","article-title":"ABO typing error resolution and transfusion support in a case of an acute leukemia patient showing loss of antigen expression","volume":"1","author":"Mishra D","year":"2019","unstructured":"Mishra D, Gopal R, Mahapatra S, Parida P. ABO typing error resolution and transfusion support in a case of an acute leukemia patient showing loss of antigen expression. Cancer Transl Med. 2019, 1:80-2.","journal-title":"Cancer Transl Med"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2018.11.010","article-title":"The disappearance of blood group antigens: A clue to the clinical diagnosis of leukemia","volume":"58","author":"Chenna D","year":"2019","unstructured":"Chenna D, Mohan G, Reddy VR, Shastry S. The disappearance of blood group antigens: A clue to the clinical diagnosis of leukemia. Transfus Apher Sci. 2019, 58:48-9. 10.1016\/j.transci.2018.11.010","journal-title":"Transfus Apher Sci"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1007\/s12098-015-2019-5","article-title":"Blood group change in pediatric leukemia: A rare phenomena","volume":"83","author":"Radhakrishnan V","year":"2016","unstructured":"Radhakrishnan V, Mishra S, Bhaskar N, Sagar T. Blood group change in pediatric leukemia: A rare phenomena. Indian J Pediatr. 2016, 83:874. 10.1007\/s12098-015-2019-5","journal-title":"Indian J Pediatr"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1016\/j.htct.2023.07.011","article-title":"ABO blood group discrepancies in blood donor and patient samples at a tertiary care oncology centre: Analysis and serological resolution","author":"Desai P","year":"2023","unstructured":"Desai P, Navkudkar A, Rajadhyaksha S. ABO blood group discrepancies in blood donor and patient samples at a tertiary care oncology centre: Analysis and serological resolution. Hematol Transfus Cell Ther. 2023, 10.1016\/j.htct.2023.07.011","journal-title":"Hematol Transfus Cell Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/234126-association-of-leukemia-with-abo-blood-group-distribution-and-discrepancy-a-review-article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,24]],"date-time":"2024-03-24T11:41:10Z","timestamp":1711280470000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/234126-association-of-leukemia-with-abo-blood-group-distribution-and-discrepancy-a-review-article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,24]]},"references-count":64,"URL":"https:\/\/doi.org\/10.7759\/cureus.56812","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3,24]]}}}